• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 10 Results
Document Number K032279
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Amikacin} 
CR260306 K032279 Amikacin Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas c 303  {ONLINE TDM Amikacin} 
CR220440 k032279 Amikacin Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics cobas c 503 analytical unit  
CR200029 K032279 Amikacin Toxicology / TDM MODERATE 02/19/2020
Roche Diagnostics cobas c 502 Analyzer  
K100853 K032279 Amikacin Toxicology / TDM MODERATE 01/10/2011
Roche Diagnostics cobas c 311 Analyzer  
K032279 K032279 Amikacin Toxicology / TDM MODERATE 08/08/2007
Roche Diagnostics cobas c501 Analyzer  
K032279 K032279 Amikacin Toxicology / TDM MODERATE 04/05/2007
Roche Diagnostics Hitachi 911 Analyzer  {ROCHE DIAGNOSTICS ONLINE TDM AMIKACIN ASSAY} 
K032279 K032279 Amikacin Toxicology / TDM MODERATE 10/10/2003
Roche Diagnostics Hitachi 912 Analyzer  {ROCHE DIAGNOSTICS ONLINE TDM AMIKACIN ASSAY} 
K032279 K032279 Amikacin Toxicology / TDM MODERATE 10/10/2003
Roche Diagnostics Hitachi 917 Analyzer  {ROCHE DIAGNOSTICS ONLINE TDM AMIKACIN ASSAY} 
K032279 K032279 Amikacin Toxicology / TDM MODERATE 10/10/2003
Roche Diagnostics Hitachi Modular P  {ROCHE DIAGNOSTICS ONLINE TDM AMIKACIN ASSAY} 
K032279 K032279 Amikacin Toxicology / TDM MODERATE 10/10/2003

-
-